Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Karlsson

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin SRobin L Thurmond, Mary Pat Beavers, Hui Cai, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
Pyrazole-based cathepsin S inhibitors with improved cellular potencyJianmei Wei, Barbara A Pio, Hui Cai, et al.
Acta Physiologica (Oxford, England)|October 23, 2018
The novel antidepressant ketamine enhances dentate gyrus proliferation with no effects on synaptic plasticity or hippocampal function in depressive-like ratsHenrik Michaëlsson, Mats Andersson, Johan Svensson, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potencyMichael K Ameriks, Hui Cai, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elementsMichael K Ameriks, Frank U Axe, Scott D Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2Danielle K Neff, Alice Lee-Dutra, Jonathan M Blevitt, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsivenessNavin L Rao, Jason P Riley, Homayon Banie, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin SRobin L Thurmond, Mary Pat Beavers, Hui Cai, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
Pyrazole-based cathepsin S inhibitors with improved cellular potencyJianmei Wei, Barbara A Pio, Hui Cai, et al.
Acta Physiologica (Oxford, England)|October 23, 2018
The novel antidepressant ketamine enhances dentate gyrus proliferation with no effects on synaptic plasticity or hippocampal function in depressive-like ratsHenrik Michaëlsson, Mats Andersson, Johan Svensson, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potencyMichael K Ameriks, Hui Cai, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elementsMichael K Ameriks, Frank U Axe, Scott D Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2Danielle K Neff, Alice Lee-Dutra, Jonathan M Blevitt, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsivenessNavin L Rao, Jason P Riley, Homayon Banie, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.
Pageof 8